Sobi™ publishes the report for the second quarter 2018
Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces the results for the second quarter 2018. Total revenues grew 40 per cent compared with Q2 2017 (36 per cent at constant exchange rates, CER) and amounted to SEK 2,289 M. EBITA was SEK 951 M, an increase of 94 per cent for the quarter, and gross margin amounted to 73 per cent. Q2 outperforms our expectations · Total revenues of SEK 2,289 M (1,639) for Q2 and SEK 4,253 M (3,035) for H1 · 40 per cent sales growth in the quarter compared with Q2 2017 (36 per cent at CER) · EBITA increased by 94 per